Drug test firm in AIM debut

A company that has devised an on-the-spot test to detect drug abuse was today set to debut on the London stock market with a value of £27m (€40.5m).

Cozart, based at Abingdon in Oxfordshire, has forged a close relationship with the British Home Office for the use of its portable RapiScan system in the fight against drugs.